Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cohort Study Evaluating Glycaemic Control in Individuals with Type 2 Diabetes Mellitus Through Digital Therapeutics (DM DTx)
Sponsor: EVYD Technology
Summary
This study is conducted to evaluate the effectiveness of Digital therapeutics (DTx) in managing patients with Type 2 Diabetes Mellitus (T2DM) by delivering digital lifestyle interventions through a national health application (BruHealth).
Official title: Phase 2 Research Study for Type 2 Diabetes Mellitus Through Digital Therapeutics
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
500
Start Date
2024-08-20
Completion Date
2025-07
Last Updated
2025-02-06
Healthy Volunteers
No
Conditions
Interventions
16-week digital intervention
Participants will be enrolled in a 16-week programme with the aim to manage T2DM through lifestyle adjustments. Participants will be given online support by their personal health coach with additional support from a dietitian or clinician in the study if required. Each participant will receive personalised recommendations for blood glucose monitoring schedule, diet and physical activity. Participants are required to log their blood glucose, diet and physical activity in the BruHealth application. Participants will review their progress with their health coach via video consultation on a regular basis. Additionally, participants will also participate in a structured diabetes self-management education course.
Locations (1)
EVYD Technology
Bandar Seri Begawan, Brunei